Kymera Therapeutics KYMR Institutional Ownership

NASDAQ KYMR

$112.55 -0.91 (-0.80%)

As of: Oct 21, 2026 · 3:59 PM EDT

Institutions by Trading Activity

277 Institutions

Increased 144 52.0%

Unchanged 48 17.3%

Reduced 85 30.7%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

98.75%

▲+0.02 pp QoQ

Shares Held by Institutions

96.95Mn

of 98.18Mn outstanding

▲+0.68% QoQ

Shares Outstanding

98.18Mn

1.23Mn held outside 13F filers

Institutional Investors

277

filed 13F for Jun 2026

▲+23 vs prior quarter

Net Shares Added (QoQ)

+653.54K

accumulated since last quarter

Value of Holdings

$11.00Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 11, 2026

Kymera Therapeutics, Inc. (NASDAQ:KYMR) counted 277 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

Collectively, these holders controlled 98.75% of Kymera Therapeutics' outstanding shares in Q2 2026, up from 98.73% in Q1 2026.
Total shares held in KYMR rose 0.68% from Q1 2026; the number of holders rose 33.82% from Q2 2025.
Of these 277 holders, 144 added to their positions, 85 reduced their stakes and 48 left their positions unchanged.
Institutional investors held 96.95Mn shares of Kymera Therapeutics in total at the end of Q2 2026, up 653.54K from the prior quarter and up 18.9Mn from a year earlier.
FMR LLC held the largest position in KYMR at 12.35Mn shares as of June 30, 2026, or 12.58% of shares outstanding.
Among holders that already owned Kymera Therapeutics, the biggest buyers in Q2 2026 were T. Rowe Price Associates Inc (+1.05Mn shares), T. Rowe Price Investment Management, Inc. (+792.26K shares), FMR LLC (+649.31K shares), BlackRock, Inc. (+477.33K shares) and State Street Corp (+347.46K shares).
Among holders that kept a stake in Kymera Therapeutics, the biggest sellers in Q2 2026 were Atlas Venture Life Science Advisors, LLC (-1.73Mn shares), BVF Inc (-1.63Mn shares), Commodore Capital LP (-500K shares), Capital Research Global Investors (-284.39K shares) and Siren, L.L.C. (-251K shares).
Business Quant data shows the 10 biggest positions in Kymera Therapeutics as of Q2 2026 were held by FMR LLC (12.35Mn shares), Baker Bros. Advisors LP (8.66Mn shares), Avoro Capital Advisors LLC (7.47Mn shares), T. Rowe Price Associates Inc (7.11Mn shares), T. Rowe Price Investment Management, Inc. (6.26Mn shares), BlackRock, Inc. (5.54Mn shares), BVF Inc (3.87Mn shares), Wellington Management Group LLP (3.68Mn shares), Vanguard Portfolio Management LLC (2.99Mn shares) and Siren, L.L.C. (2.94Mn shares).

Form 13F Holdings

278 Institutional Holders

Report period 30 Jun, 2026

Total shares held 96.95Mn

Of outstanding 98.75%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	FMR LLC	0000315066	12,349,256	12.58%	▲649,306	+5.55%	$1.42Bn
2	BAKER BROS. ADVISORS LP	0001263508	8,657,242	8.82%	0	0.00%	$992.73Mn
3	Avoro Capital Advisors LLC	0001633313	7,474,747	7.61%	0	0.00%	$857.13Mn
4	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	7,112,980	7.25%	▲1,052,133	+17.36%	$815.65K
5	T. Rowe Price Investment Management, Inc.	0001897612	6,257,261	6.37%	▲792,264	+14.50%	$717.52K
6	BlackRock, Inc.	0002012383	5,538,210	5.64%	▲477,334	+9.43%	$635.07Mn
7	BVF INC/IL	0001056807	3,872,052	3.94%	▼1,630,658	-29.63%	$444.01Mn
8	WELLINGTON MANAGEMENT GROUP LLP	0000902219	3,675,028	3.74%	▼214,659	-5.52%	$421.42Mn
9	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	2,992,193	3.05%	▲118,137	+4.11%	$343.11Mn
10	Siren, L.L.C.	0002005245	2,935,830	2.99%	▼251,000	-7.88%	$336.65Mn
11	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	2,932,378	2.99%	▲52,054	+1.81%	$336.26Mn
12	Atlas Venture Life Science Advisors, LLC	0001917529	2,847,541	2.90%	▼1,730,467	-37.80%	$326.53Mn
13	State Street Corp	0000093751	2,737,226	2.79%	▲347,459	+14.54%	$313.88Mn
14	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,816,331	1.85%	▲170,981	+10.39%	$208.32Mn
15	Capital Research Global Investors	0001422848	1,388,881	1.41%	▼284,394	-17.00%	$159.26Mn
16	Goldman Sachs Group Inc	0000886982	1,187,333	1.21%	▲298,924	+33.65%	$136.15Mn
17	UBS Group AG	0001610520	1,007,777	1.03%	▼16,075	-1.57%	$115.56Mn
18	ALLIANCEBERNSTEIN L.P.	0001109448	981,521	1.00%	▲93,486	+10.53%	$81.75Mn
19	DRIEHAUS CAPITAL MANAGEMENT LLC	0000938206	919,233	0.94%	▼124,350	-11.92%	$105.41Mn
20	Merck & Co., Inc.	0000310158	772,165	0.79%	0	0.00%	$88.54Mn

Showing 1 to 20 of 278 holders